170 related articles for article (PubMed ID: 24279871)
1. G-CSF/anti-G-CSF antibody complexes drive the potent recovery and expansion of CD11b+Gr-1+ myeloid cells without compromising CD8+ T cell immune responses.
Rubinstein MP; Salem ML; Doedens AL; Moore CJ; Chiuzan C; Rivell GL; Cole DJ; Goldrath AW
J Hematol Oncol; 2013 Oct; 6():75. PubMed ID: 24279871
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the anti-tumor effects of an anti-Human Epidermal growth factor receptor 2 (HER2) monoclonal antibody in combination with CD11b
Ramezani-Aliakbari K; Khaki-Bakhtiarvand V; Mahmoudian J; Asgarian-Omran H; Shokri F; Hojjat-Farsangi M; Jeddi-Tehrani M; Shabani M
Int Immunopharmacol; 2023 Aug; 121():110463. PubMed ID: 37327513
[TBL] [Abstract][Full Text] [Related]
3. Effect of administration timing of postchemotherapy granulocyte colony-stimulating factor on host-immune cell recovery and CD8
Salem ML; Nassef M; Abdel Salam SG; Zidan A; Mahmoud MH; Badr G; Rubinstein M; Cole D
J Immunotoxicol; 2016 Nov; 13(6):784-792. PubMed ID: 27417188
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of in vitro and in vivo anti-tumor activity of anti-GD2 monoclonal antibody 220-51 against human neuroblastoma by granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor.
Fukuda M; Horibe K; Furukawa K
Int J Mol Med; 1998 Oct; 2(4):471-5. PubMed ID: 9857237
[TBL] [Abstract][Full Text] [Related]
5. Combination of an agonistic anti-CD40 monoclonal antibody and the COX-2 inhibitor celecoxib induces anti-glioma effects by promotion of type-1 immunity in myeloid cells and T-cells.
Kosaka A; Ohkuri T; Okada H
Cancer Immunol Immunother; 2014 Aug; 63(8):847-57. PubMed ID: 24878890
[TBL] [Abstract][Full Text] [Related]
6. Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF.
Dolcetti L; Peranzoni E; Ugel S; Marigo I; Fernandez Gomez A; Mesa C; Geilich M; Winkels G; Traggiai E; Casati A; Grassi F; Bronte V
Eur J Immunol; 2010 Jan; 40(1):22-35. PubMed ID: 19941314
[TBL] [Abstract][Full Text] [Related]
7. Granulocyte colony-stimulating factor-induced immature myeloid cells inhibit acute graft-versus-host disease lethality through an indoleamine dioxygenase-independent mechanism.
Joo YD; Lee SM; Lee SW; Lee WS; Lee SM; Park JK; Choi IW; Park SG; Choi I; Seo SK
Immunology; 2009 Sep; 128(1 Suppl):e632-40. PubMed ID: 19740324
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 Nef Induces Hck/Lyn-Dependent Expansion of Myeloid-Derived Suppressor Cells Associated with Elevated Interleukin-17/G-CSF Levels.
Priceputu E; Cool M; Bouchard N; Caceres-Cortes JR; Lowell CA; Hanna Z; Jolicoeur P
J Virol; 2021 Aug; 95(17):e0047121. PubMed ID: 34106001
[TBL] [Abstract][Full Text] [Related]
9. Liver myeloid-derived suppressor cells expand in response to liver metastases in mice and inhibit the anti-tumor efficacy of anti-CEA CAR-T.
Burga RA; Thorn M; Point GR; Guha P; Nguyen CT; Licata LA; DeMatteo RP; Ayala A; Joseph Espat N; Junghans RP; Katz SC
Cancer Immunol Immunother; 2015 Jul; 64(7):817-29. PubMed ID: 25850344
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-6 induces Gr-1+CD11b+ myeloid cells to suppress CD8+ T cell-mediated liver injury in mice.
Cheng L; Wang J; Li X; Xing Q; Du P; Su L; Wang S
PLoS One; 2011 Mar; 6(3):e17631. PubMed ID: 21394214
[TBL] [Abstract][Full Text] [Related]
11. Granulocyte Colony-Stimulating Factor Attenuates Renal Ischemia-Reperfusion Injury by Inducing Myeloid-Derived Suppressor Cells.
Yan JJ; Ryu JH; Piao H; Hwang JH; Han D; Lee SK; Jang JY; Lee J; Koo TY; Yang J
J Am Soc Nephrol; 2020 Apr; 31(4):731-746. PubMed ID: 32132198
[TBL] [Abstract][Full Text] [Related]
12. Role of immature myeloid Gr-1+ cells in the development of antitumor immunity.
Li Q; Pan PY; Gu P; Xu D; Chen SH
Cancer Res; 2004 Feb; 64(3):1130-9. PubMed ID: 14871848
[TBL] [Abstract][Full Text] [Related]
13. Distinct chemotherapy-associated anti-cancer immunity by myeloid cells inhibition in murine pancreatic cancer models.
Sakai Y; Miyazawa M; Komura T; Yamada T; Nasti A; Yoshida K; Takabatake H; Yamato M; Yamashita T; Yamashita T; Mizukoshi E; Okuzono M; Ho TTB; Kawaguchi K; Wada T; Honda M; Kaneko S
Cancer Sci; 2019 Mar; 110(3):903-912. PubMed ID: 30657234
[TBL] [Abstract][Full Text] [Related]
14. In vivo expansion of activated naive CD8+ T cells and NK cells driven by complexes of IL-2 and anti-IL-2 monoclonal antibody as novel approach of cancer immunotherapy.
Tomala J; Chmelova H; Mrkvan T; Rihova B; Kovar M
J Immunol; 2009 Oct; 183(8):4904-12. PubMed ID: 19801515
[TBL] [Abstract][Full Text] [Related]
15. IFN-γ regulates survival and function of tumor-induced CD11b+ Gr-1high myeloid derived suppressor cells by modulating the anti-apoptotic molecule Bcl2a1.
Medina-Echeverz J; Haile LA; Zhao F; Gamrekelashvili J; Ma C; Métais JY; Dunbar CE; Kapoor V; Manns MP; Korangy F; Greten TF
Eur J Immunol; 2014 Aug; 44(8):2457-67. PubMed ID: 24810636
[TBL] [Abstract][Full Text] [Related]
16. Critical Role of Mast Cells and Peroxisome Proliferator-Activated Receptor γ in the Induction of Myeloid-Derived Suppressor Cells by Marijuana Cannabidiol In Vivo.
Hegde VL; Singh UP; Nagarkatti PS; Nagarkatti M
J Immunol; 2015 Jun; 194(11):5211-22. PubMed ID: 25917103
[TBL] [Abstract][Full Text] [Related]
17. Tumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1.
Lu R; Kujawski M; Pan H; Shively JE
Cancer Res; 2012 May; 72(9):2239-50. PubMed ID: 22406619
[TBL] [Abstract][Full Text] [Related]
18. G-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment.
Martinez Sanz P; van Rees DJ; van Zogchel LMJ; Klein B; Bouti P; Olsman H; Schornagel K; Kok I; Sunak A; Leeuwenburg K; Timmerman I; Dierselhuis MP; Kholosy WM; Molenaar JJ; van Bruggen R; van den Berg TK; Kuijpers TW; Matlung HL; Tytgat GAM; Franke K
J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34049929
[TBL] [Abstract][Full Text] [Related]
19. Myeloid cells as effector cells for monoclonal antibody therapy of cancer.
Braster R; O'Toole T; van Egmond M
Methods; 2014 Jan; 65(1):28-37. PubMed ID: 23811299
[TBL] [Abstract][Full Text] [Related]
20. Differently immunogenic cancers in mice induce immature myeloid cells that suppress CTL in vitro but not in vivo following transfer.
Schmidt K; Zilio S; Schmollinger JC; Bronte V; Blankenstein T; Willimsky G
Blood; 2013 Mar; 121(10):1740-8. PubMed ID: 23305737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
